Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subarachnoid autologous bone marrow stromal cells for chronic incomplete spinal cord injury
2011-005684-24Phase 2Completed
- Sponsor
- Fundación de Investigación Biomédica Hospital Puerta de Hierro
- Start
- Oct 2013
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow stromal cells in spinal cord injury (SCI) and spinal cord infarction (SCInf), sponsored by Fundación de Investigación Biomédica Hospital Puerta de Hierro. Primary endpoints: Change in ASIA scale, Change in Frankel scale and 6 more. Started Oct 2013; status: completed.
02
Drugs
autologous bone marrow stromal cells
03
Conditions
spinal cord injury (SCI)spinal cord infarction (SCInf)
Beyond the preview
Go deeper on 2011-005684-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005684-24.